v3.24.2.u1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Sep. 30, 2023
Assets    
Cash and cash equivalents $ 29,150,879 $ 9,625,494
Accounts receivable, net 1,642,063 4,506,508
Inventories, net 4,942,246 6,697,117
Prepaid research and development costs 1,125,699 1,006,252
Prepaid expenses and other current assets 1,615,254 1,097,851
Total current assets 38,476,141 22,933,222
Plant and equipment, net 1,491,129 1,652,732
Operating lease right-of-use assets 3,756,812 4,332,473
Investments in equity securities 228,824 0
Deferred income taxes 12,479,488 12,707,419
Goodwill 6,878,932 6,878,932
Other assets 1,320,328 1,518,313
Total assets 64,631,654 50,023,091
Liabilities and Stockholders' Equity    
Accounts payable 3,018,334 12,931,172
Accrued compensation 3,385,464 990,609
Accrued expenses and other current liabilities 2,191,054 1,987,738
Residual royalty agreement liability, short-term portion 986,388 864,623
Operating lease liability, short-term portion 1,038,795 1,036,590
Total current liabilities 10,620,035 17,810,732
Residual royalty agreement liability, long-term portion 8,577,067 8,870,136
Operating lease liability, long-term portion 3,074,721 3,634,114
Other liabilities 4,739,375 29,948
Total liabilities 27,011,198 30,344,930
Commitments and contingencies (Note 12)
Stockholders' equity:    
Preferred stock; no shares issued and outstanding at June 30, 2024 and September 30, 2023 0 0
Common stock, par value $0.01 per share; 308,000,000 shares authorized, 148,567,624 and 93,966,402 shares issued and 146,383,920 and 91,782,698 shares outstanding at June 30, 2024 and September 30, 2023, respectively 1,485,676 939,664
Additional paid-in-capital 330,561,916 283,894,830
Accumulated other comprehensive loss (581,519) (581,519)
Accumulated deficit (286,039,012) (256,768,209)
Treasury stock, 2,183,704 shares, at cost (7,806,605) (7,806,605)
Total stockholders' equity 37,620,456 19,678,161
Total liabilities and stockholders' equity $ 64,631,654 $ 50,023,091

Source

PDF HTML
ZIP XLS HTML